(AOF) – Implanet announces the success of the capital increase in cash with maintenance of shareholders’ preferential subscription rights announced on January 4, 2024. The medtech specialist in spinal implants specifies that this operation made it possible to raise an amount of 5, 5 million euros through the issue of approximately 83.924 million new shares at a unit price of 0.0655 euros corresponding to the closing price on January 3. The gross proceeds will enable the company to finance its anticipated cash flow needs for the next 12 months.
At the end of the operation, Sanyou Medical, a company specializing in innovative orthopedic products, holds 74.56% of the capital and voting rights of Implanet, compared to 41.03% of the capital previously, the remaining float of 22. 33%. On October 31, 2023, Sanyou Medical obtained an exemption from the obligation to file a mandatory public purchase offer from the Financial Markets Authority (AMF).
The participation of a shareholder who held 1% of the company’s capital prior to the capital increase and who did not subscribe to it is reduced to 0.328%.
AOF – LEARN MORE
Learn more about the Pharmacy sector
Oncology, priority of pharmaceutical giants
Sanofi’s stock market disappointment recorded at the end of October 2023 underlines the new direction for the group, which has now set oncology as its number 1 priority. Efforts in this segment, where therapies are advancing the fastest, notably involve investments in R&D which weigh on profitability. Sanofi therefore announced a drop in its earnings per share in 2024 and the abandonment of its objective of an operating margin of 32% in 2025. Merck has just unveiled a new alliance. It will pay up to $22 billion to the Japanese group Daiichi Sankyo as part of a partnership on experimental cancer treatments. While some experts estimate that the United States represents nearly half of global oncology spending (drugs and treatments), or $196 billion in 2022, Chinese spending in this area has more than doubled in five years, going from 5 to 11.8 billion dollars.